Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Quinazolinone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108101904B reveals a copper-catalyzed route for quinolinoquinazolinone derivatives, offering high yields and scalable production for anti-tumor pharmaceutical intermediates.
Patent CN115850193B details copper-catalyzed quinazolinone synthesis offering high yield and selectivity for scalable pharmaceutical intermediate manufacturing supply chains.
Patent CN112876470B reveals a metal-free route to quinazolinones using N,B-doped carbon catalysts, offering high purity and cost efficiency for pharmaceutical intermediates.
Patent CN119707988A reveals green photocatalytic route for antiviral quinazolinones offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN108033919B details a novel Pd-catalyzed oxidative cleavage route using styrenes, offering cost-effective manufacturing for high-purity pharmaceutical intermediates.
Patent CN110776470B details an iridium-catalyzed asymmetric hydrogenation method for chiral 3,4-dihydroquinazolinones with up to 98% ee, offering a scalable route for API intermediates.
Novel Pd-catalyzed route for quinazolinone pyrazole compounds. Enhances yield and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN108822046B reveals a metal-free, room-temperature route for quinazolinones. Discover cost-effective manufacturing and reliable supply chain solutions for pharmaceutical intermediates.
Novel room temperature oxidation method for quinazolinones. Reduces cost and improves supply chain reliability for pharmaceutical intermediates manufacturing globally with high purity standards.
Patent CN108129402B reveals a novel Pd-catalyzed route using tolane and oxygen. This method offers high yields and simplified purification for reliable pharmaceutical intermediate suppliers.
Patent CN112047933B discloses a novel quinazolinone USP7 inhibitor synthesis with high yield and mild conditions, offering cost-effective solutions for pharmaceutical intermediates.
Patent CN105732521B reveals a metal-free TEMPO catalytic route for dihydroquinazolinone derivatives, offering high purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN110372611A reveals green solvent-free synthesis using heteropolyacid ionic liquids for high-purity quinazolinone intermediates ensuring cost reduction and supply reliability.
Patent CN112778218A reveals a green method for quinazolinone derivatives using recyclable chitosan-copper catalyst, offering cost reduction and supply chain reliability.
Novel Ru-catalyzed synthesis of trifluoromethyl quinazolinones. High yield, green solvent, excellent antibacterial activity for agrochemical manufacturing.
Patent CN119490461A reveals metal-free synthesis for high-purity quinazolinone derivatives offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturing.
Patent CN106432103A reveals Au/TiO2 catalyzed quinazolinone synthesis. Offers high yield, recyclable catalyst, and scalable process for reliable pharmaceutical intermediates supplier partnerships.
Patent CN118772160A reveals a visible-light photocatalytic synthesis for trifluoromethyl dihydropyrroloquinazolinones, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN1042914A reveals a high-yield route for spiro-quinazolinone derivatives. Discover cost-effective manufacturing strategies for diabetic complication intermediates.
Patent CN1827605A details a metal-free route to HIV drug precursors. Discover cost reduction in API manufacturing and reliable pharmaceutical intermediate supply.